ADC Therapeutics (ADCT) Gross Profit (2021 - 2026)
ADC Therapeutics (ADCT) posted Gross Profit of $17.4 million for Q1 2026, up 14.18% sequentially from $15.2 million in Q3 2025, and down 17.11% YoY from $21.0 million in Q1 2025.
ADC Therapeutics (ADCT) Gross Profit (2021 - 2026) Analysis & Trends
ADC Therapeutics has reported Gross Profit for 6 years, with the latest figure at $17.4 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.14 Mn |
| Jun 30, 2026 | 17.14 Mn |
| Mar 31, 2026 | 17.38 Mn |
| Mar 31, 2026 | 17.38 Mn |
| Sep 30, 2025 | 15.23 Mn |
| Sep 30, 2025 | 15.23 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | 20.97 Mn |
| Mar 31, 2025 | 20.97 Mn |
| Sep 30, 2024 | 17.61 Mn |
| Sep 30, 2024 | 17.61 Mn |
| Jun 30, 2024 | 16.19 Mn |
| Jun 30, 2024 | 16.19 Mn |
| Mar 31, 2024 | 15.54 Mn |
| Mar 31, 2024 | 15.54 Mn |
| Sep 30, 2023 | 14.13 Mn |
| Sep 30, 2023 | 14.13 Mn |
| Jun 30, 2023 | 17.96 Mn |
| Jun 30, 2023 | 17.96 Mn |